Key statistics
On Tuesday, RAPT Therapeutics Inc (RAPT:NMQ) closed at 7.33, 29.39% above the 52 week low of 5.67 set on May 15, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.94 |
---|---|
High | 8.06 |
Low | 7.33 |
Bid | 7.00 |
Offer | 9.58 |
Previous close | 8.00 |
Average volume | 163.98k |
---|---|
Shares outstanding | 16.54m |
Free float | 12.71m |
P/E (TTM) | -- |
Market cap | 132.29m USD |
EPS (TTM) | -19.25 USD |
Data delayed at least 15 minutes, as of Jul 01 2025 21:00 BST.
More ▼
- RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
- RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
- RAPT Therapeutics to Participate in Upcoming Investor Conferences
- RAPT Therapeutics Reports First Quarter 2025 Financial Results
- RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
- RAPT Therapeutics to Participate in Upcoming Investor Conferences
- RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
- RAPT Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
- RAPT Therapeutics Names Lori Lyons-Williams Chair of the Company’s Board of Directors
- RAPT Therapeutics Announces $150 Million Private Placement
More ▼